FDA.reportPublic FDA data

Axe

Manufacturer
Conopco, Inc. d/b/a/ Unilever
Effective date
2021-12-01
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:45:19

Label at a glance#

ProductAxe Forest Antiperspirant and Deodorant
Active ingredientALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY
Label structure10 sections

Indications and uses

• reduces underarm wetness

Dosage and administration

apply to underarms only

Label contents#

Full prescribing information#

AXE FOREST ANTIPERSPIRANT AND DEODORANT - aluminum zirconium tetrachlorohydrex gly stick

DESCRIPTION SECTION

Axe Forest Antiperspirant and Deodorant

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient


Aluminum Zirconium Tetrachlorohydrex GLY (11.4 %)

Purpose

OTC - PURPOSE SECTION

antiperspirant

Uses

INDICATIONS & USAGE SECTION

• reduces underarm wetness

Warnings

WARNINGS SECTION

For external use only

Do not use on broken skin

Ask a doctor before use if you have kidney disease

Stop use if rash or irritation occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

apply to underarms only

Inactive ingredients

INACTIVE INGREDIENT SECTION

Cyclopentasiloxane, PPG-14 Butyl Ether, Stearyl Alcohol, Polyethylene, Hydrogenated Castor Oil, PEG-8 Distearate, Fragrance (Parfum), Silica, BHT.

Questions?

OTC - QUESTIONS SECTION

Call toll-free 1-800-450-7580

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

AxeForestAPDeoAxeForestAPDeo

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64942-1543-12025-01-30C16284748780-19d75b9d0-6061-f424-e053-dadaa90a57ceAxe Forest Antiperspirant and Deodorant
64942-1543-12021-12-01C16284748780-19d75b9d0-6061-f424-e053-dadaa90a57ceAxe Forest Antiperspirant and Deodorant
64942-1543-12020-01-31C16284748780-19d75b9d0-6061-f424-e053-dadaa90a57ceAxe Forest Antiperspirant and Deodorant

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64942-1543-1AxeForest Antiperspirant and Deodorant76 g in 1 CONTAINERSTICK762

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64942-1543AXE FOREST ANTIPERSPIRANT AND DEODORANT (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) STICK [CONOPCO, INC. D/B/A/ UNILEVER]2Legacy NDC, 1 package rows20211202_5a35ee5e-7c08-976f-e053-2991aa0af5f0.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64942-154364942-1543-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
NameUNIIKind
CYCLOMETHICONE 50THT5PCI0RIACT
PPG-14 BUTYL ETHERR199TJT95TIACT
STEARYL ALCOHOL2KR89I4H1YIACT
HIGH DENSITY POLYETHYLENEUG00KM4WR7IACT
HYDROGENATED CASTOR OILZF94AP8MEYIACT
PEG-8 DISTEARATE7JNC8VN07MIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
BUTYLATED HYDROXYTOLUENE1P9D0Z171KIACT
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY8O386558JEACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d2193410-ea28-2898-e053-2a95a90a83bc5a35ee5e-7c08-976f-e053-2991aa0af5f02021-12-01WarningsExact identifier
spl id: d2193410-ea28-2898-e053-2a95a90a83bc
spl set id: 5a35ee5e-7c08-976f-e053-2991aa0af5f0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.